BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Krill RA, Kumra S. Metabolic consequences of second-generation antipsychotics in youth: appropriate monitoring and clinical management. Adolesc Health Med Ther 2014;5:171-82. [PMID: 25298741 DOI: 10.2147/AHMT.S49807] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
Number Citing Articles
1 D'Alò GL, De Crescenzo F, Amato L, Cruciani F, Davoli M, Fulceri F, Minozzi S, Mitrova Z, Morgano GP, Nardocci F, Saulle R, Schünemann HJ, Scattoni ML; ISACA guideline working group. Acceptability, equity, and feasibility of using antipsychotics in children and adolescents with autism spectrum disorder: a systematic review. BMC Psychiatry 2020;20:561. [PMID: 33238921 DOI: 10.1186/s12888-020-02956-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Kauffman YS, Delate T, Botts S. Metabolic monitoring in children 5 years of age and younger prescribed second-generation antipsychotic medications. Ment Health Clin 2017;7:1-6. [PMID: 29955489 DOI: 10.9740/mhc.2017.01.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]